当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
The market for chimeric antigen receptor T cell therapies
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-01-29 , DOI: 10.1038/nrd.2017.266 Amy Yip , Rachel M. Webster
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2018-01-29 , DOI: 10.1038/nrd.2017.266 Amy Yip , Rachel M. Webster
The market for chimeric antigen receptor T cell therapies
中文翻译:
嵌合抗原受体T细胞疗法的市场
嵌合抗原受体T细胞疗法的市场
更新日期:2018-01-29
The market for chimeric antigen receptor T cell therapies, Published online: 29 January 2018; doi:10.1038/nrd.2017.266
This article discusses the market for chimeric antigen receptor (CAR) T cell therapies, focusing on haematological malignancies.中文翻译:
嵌合抗原受体T细胞疗法的市场
嵌合抗原受体T细胞疗法的市场
嵌合抗原受体T细胞疗法的市场,在线发布:2018年1月29日; doi:10.1038 / nrd.2017.266
本文讨论了嵌合抗原受体(CAR)T细胞疗法的市场,重点是血液系统恶性肿瘤。